在老年人中,SPI1促进微骨折介导的软骨再生,通过增强骨髓 stromal 细胞质量
Changjiang Wang1, Yishu Wang1, Yueqiang Gu1
1Department of Sports Medicine and Joint Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Journal of tissue engineering
|January 7, 2025
概括
在老年人中,通过SPI1增强老骨髓 stromal 细胞 (BMSCs) 的干性,可以改善微骨折手术后的软骨再生. 这项研究将SPI1确定为改善老年患者治疗结果的关键目标.
科学领域:
- 整形外科和再生医学
- 细胞生物学和干细胞研究
- 老年学是指老年学的学科.
背景情况:
- 微骨折手术是关节软骨损伤的常见治疗方法.
- 与年轻人相比,老年患者的软骨再生结果较差.
- 衰老减少了骨髓 stromal 细胞 (BMSCs) 的干细胞能力,这可能解释了治疗效率的降低.
研究的目的:
- 调查老年人BMSC的茎和微骨折结果之间的相关性.
- 确定分子点,以增强老年BMSC的茎性和体潜力.
- 评估向茎的治疗潜力,以改善老年人微骨折诱导的软骨再生.
主要方法:
- 临床数据和动物实验的相关性分析,将BMSC干与微骨折结果联系起来.
- 开发模拟微骨折引起的软骨再生的体外有机体模型.
- 在体外和体内实验涉及SPI1过度表达和老老鼠的5-Aza-2'-deoxycytidine (5Aza) 治疗.
主要成果:
- 在老年人中,BMSC茎度和微骨折手术成功率之间观察到正相关性.
- SPI1被确定为一种增强旧BMSCs (OBMSCs) 的干性和基生成的基因.
- 在OBMSC中SPI1的过度表达显著改善了老老鼠的软骨再生,而5Aza治疗上调了SPI1,提高了微骨折的结果.
结论:
- 在老年人中,BMSC茎是影响微骨折手术成功的关键因素.
- SPI1是增强OBMSC干性和原体潜力的新目标.
- 针对SPI1提供了一种有希望的策略,以改善老年人群中微骨折刺激的软骨再生.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Stem Cell Niche
4.9K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
4.9K
Bone Remodeling
38.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K


